baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AbbVie Inc/ US00287Y1091 /

- -	Chg. -	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
-CHF	-	- Turnover: -	-Bid Size: -	-Ask Size: -	271.66 bill.CHF	-	-

Newsfile Corp 10:36 PM ROSEN, A LEADING NATIONAL FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure C...

GlobeNewswire 10:19 PM ROSEN, A TOP RANKED LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Cou...

GlobeNewswire 10:00 PM CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

GlobeNewswire 5:56 PM Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: ...

Newsfile Corp 4/24 CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

Newsfile Corp 4/24 ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Se...

GlobeNewswire 4/24 Lost Money on Cerevel Therapeutics Holdings, Inc.(ABBV)? Join Class Action Suit Seeking Recovery – C...

GlobeNewswire 4/24 iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in...

GlobeNewswire 4/23 Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced A...

GlobeNewswire 4/23 Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Th...

GlobeNewswire 4/22 Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

GlobeNewswire 4/22 ROSEN, A LEADING NATIONAL FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure C...

Newsfile Corp 4/22 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure C...

GlobeNewswire 4/22 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sol...

GlobeNewswire 4/21 Royalty Pharma Declares Second Quarter 2025 Dividend

GlobeNewswire 4/21 Galapagos Announces Executive Leadership Updates

GlobeNewswire 4/21 Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors...

GlobeNewswire 4/21 Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: ...

Newsfile Corp 4/21 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors ...

GlobeNewswire 4/18 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure C...

Newsfile Corp 4/18 CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

GlobeNewswire 4/18 CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings,...

GlobeNewswire 4/18 Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Le...

GlobeNewswire 4/18 Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: ...

AbbVie Inc/ US00287Y1091 /

If you wish to receive reply to your feedback, please provide your email address.